BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 208880)

  • 1. The effect of different regimens of oestrogens on the clotting and fibrinolytic system of the post-menopausal woman.
    Thom M; Dubiel M; Kakkar VV; Studd JW
    Front Horm Res; 1977; 5():192-202. PubMed ID: 208880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugated equine oestrogens and blood clotting: a follow-up report.
    Poller L; Thomson JM; Coope J
    Br Med J; 1977 Apr; 1(6066):935-6. PubMed ID: 192405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of natural oestrogens on coagulation.
    Notelovitz M; Greig HB
    S Afr Med J; 1975 Jan; 49(4):101-5. PubMed ID: 164700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on glucose tolerance in postmenopausal women.
    Thom M; Chakravarti S; Oram DH; Studd JW
    Br J Obstet Gynaecol; 1977 Oct; 84(10):776-83. PubMed ID: 200256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
    Varma TR
    Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation, fibrinolysis, and contraceptive hormones.
    Brakman P; Albrechtsen OK; Astrup T
    JAMA; 1967 Jan; 199(2):69-74. PubMed ID: 6071154
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study.
    Ygge J; Brody S; Korsan-Bengtsen K; Nilsson L
    Am J Obstet Gynecol; 1969 May; 104(1):87-98. PubMed ID: 4180662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric.
    Aylward M
    Postgrad Med J; 1978; 54 Suppl 2():31-7. PubMed ID: 740578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.
    Howie PW; Mallinson AC; Prentice CR; Horne CH; McNicol GP
    Lancet; 1970 Dec; 2(7687):1329-32. PubMed ID: 4098907
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic hormone therapy in climacteric and menopausal women in Iran. Report of 600 cases.
    Taleghany P
    Int Surg; 1971 Aug; 56(2):78-81. PubMed ID: 4327046
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of lactation suppressants on the coagulation mechanism.
    Wodzicki AM; Coopland AT
    Can Med Assoc J; 1974 Apr; 110(8):905-9. PubMed ID: 4824964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of testosterone improves the prothrombotic and antifibrinolytic parameters associated with its deficiency in an orchidectiomized rat model.
    Alqahtani SA; Alhawiti NM
    Platelets; 2019; 30(5):624-630. PubMed ID: 30102104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.